1,911
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Permeation-enhancing effects and mechanisms of O-acylterpineol on isosorbide dinitrate: mechanistic insights based on ATR-FTIR spectroscopy, molecular modeling, and CLSM images

, , , , &
Pages 107-119 | Received 23 Oct 2018, Accepted 17 Dec 2018, Published online: 11 Feb 2019

References

  • Alvarez-Román R, Naik A, Kalia YK, et al. (2004). Enhancement of topical delivery from biodegradable nanoparticles. Pharm Res 21:1818–25.
  • Baldassarre M, Li C, Eremina N, et al. (2015). Simultaneous fitting of absorption spectra and their second derivatives for an improved analysis of protein infrared spectra. Molecules 20:12599–622.
  • Bhatia KS, Gao S, Singh J. (1997). Effect of penetration enhancers and iontophoresis on the FT-IR spectroscopy and LHRH permeability through porcine skin. J Control Release 47:81–9.
  • Cal K, Janicki S, Sznitowska M. (2001). In vitro studies on penetration of terpenes from matrix-type transdermal systems through human skin. Int J Pharm 224:81–8.
  • Casal HL, Mantsch HH. (1984). Polymorphic phase behaviour of phospholipid membranes studied by infrared spectroscopy. Biochim Biophys Acta 779:381–401.
  • Chen Y, Cun D, Quan P, et al. (2014). Saturated long-chain esters of isopulegol as novel permeation enhancers for transdermal drug delivery. Pharm Res 31:1907–18.
  • Chen Y, Wang J, Cun D, et al. (2013). Effect of unsaturated menthol analogues on the in vitro penetration of 5-fluorouracil through rat skin. Int J Pharm 443:120–7.
  • Cornwell PA, Barry BW, Bouwstra JA, et al. (1996). Modes of action of terpene penetration enhancers in human skin, differential scanning calorimetry, small-angle X-ray diffraction and enhancer uptake studies. Int J Pharm 127:9–26.
  • Dai X, Wang R, Wu Z, et al. (2018). Permeation-enhancing effects and mechanisms of borneol and menthol on Ligustrazine: a multiscale study using in vitro and coarse-grained molecular dynamics simulation methods. Chem Biol Drug Des 92:1830–7.
  • De Meutter J, Vandenameele J, Matagne A, et al. (2017). Infrared imaging of high density protein arrays. Analyst 142:1371–80.
  • Fang JY, Tsai TH, Lin YY, et al. (2007). Transdermal delivery of tea catechins and theophylline enhanced by terpenes: a mechanistic study. Biol Pharm Bull 30:343–9.
  • Gao Q, Zhao Y, Yu J, et al. (2014). Microdialysis as a tool to determine the skin concentration of mometason furoate in rats. Pharmazie 69:787–91.
  • Ghafourian T, Zandasrar P, Hamishekar H, et al. (2004). The effect of penetration enhancers on drug delivery through skin: a QSAR study. J Control Release 99:113–25.
  • Godin B, Touitou E. (2007). Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models. Adv Drug Deliv Rev 59:1152–61.
  • Grimard V, Li C, Ramjeesingh M, et al. (2004). Phosphorylation-induced conformational changes of cystic fibrosis transmembrane conductance regulator monitored by attenuated total reflection-Fourier transform IR spectroscopy and fluorescence spectroscopy. J Biol Chem 279:5528–36.
  • Hadgraft J. (1999). Passive enhancement strategies in topical and transdermal drug delivery. Int J Pharm 184:1–6.
  • Hui X, Wester RC, Zhai H, et al. (2005). Chemical partitioning into powdered human stratum corneum: a useful in vitro model for studying interaction of chemicals and human skin. In: Bronaugh RL, Maibach HI, eds. Percutaneous absorption. Boca Raton (FL): Taylor & Francis,291–302.
  • Ibrahim SA, Li SK. (2009). Effects of solvent deposited enhancers on transdermal permeation and their relationship with Emax. J Control Release 136:117–24.
  • Iyer M, Zheng T, Hopfinger AJ, et al. (2007). QSAR analyses of skin penetration enhancers. J Chem Inf Model 47:1130–49.
  • Kang L, Yap WC, Lim CFP, et al. (2007). Formulation development of transdermal dosage forms-quantitative structure–activity relationship model for predicting activities of terpenes that enhance drug penetration through human skin. J Control Release 120:211–19.
  • Krishnaiah YSR, Satyanarayana V, Karthikeyan RS. (2002). Permeation enhancing effect of menthol on the percutaneous flux of nicardipine hydrochloride through excised rat epidermis from hydroxypropyl cellulose gels. Pharm Dev Technol 7:305–15.
  • Levang AK, Zhao K, Singh J. (1999). Effect of ethanol/propylene glycol on the in vitro percutaneous absorption of aspirin, biophysical changes and the macroscopic barrier properties of the skin. Int J Pharm 181:255–63.
  • Li N, Quan P, Wan X, et al. (2017). Mechanistic insights of the enhancement effect of sorbitan monooleate on olanzapine transdermal patch both in release and percutaneous absorption processes. Eur J Pharm Sci 107:138–47.
  • Li Y, Zhao L, Liu C. (2018). Effect of chiral O-acylmenthol derivatives on in vitro permeation of flubiprofen. Chin J Pharm 49:962–7.
  • Lin SY, Duan KJ, Lin TC. (1996). Microscopic FT-IR/DSC system used to simultaneously investigate the conversion process of protein structure in porcine stratum corneum after pretreatment with skin penetration enhancers. Methods Find Exp Clin Pharmacol 18:175–81.
  • Liu C, Quan P, Fang L. (2016). Effect of drug physicochemical properties on drug release and their relationship with drug skin permeation behaviors in hydroxyl pressure sensitive adhesive. Eur J Pharm Sci 93:437–46.
  • Liu C, Quan P, Li S, et al. (2017a). A systemic evaluation of drug in acrylic pressure sensitive adhesive patch in vitro and in vivo: the roles of intermolecular interaction and adhesive mobility variation in drug controlled release. J Control Release 252:83–94.
  • Liu CH, Chang FY, Hung DK. (2011). Terpene microemulsions for transdermal curcumin delivery: effects of terpenes and cosurfactants. Colloids Surf B Biointerfaces 82:63–70.
  • Liu X, Quan P, Li S, et al. (2017b). Time dependence of the enhancement effect of chemical enhancers: molecular mechanisms of enhancing kinetics. J Control Release 248:33–44.
  • Liu X, Liu M, Liu C, et al. (2017c). An insight into the molecular mechanism of the temporary enhancement effect of isopulegol decanoate on the skin. Int J Pharm 529:161–7.
  • Marwah H, Garg T, Goyal AK, et al. (2016). Permeation enhancer strategies in transdermal drug delivery. Drug Deliv 23:1–15.
  • Morris GM, Goodsell DS, Halliday RS, et al. (1998). Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem 19:1639–62.
  • Nose T, Tsurumi K. (1993). Pharmacological studies on cutaneous inflammation induced by ultraviolet irradiation (1): quantification of erythema by reflectance colorimetry and correlation with cutaneous blood flow. Jpn J Pharmacol 62:245–56.
  • Obata Y, Utsumi S, Watanabe H, et al. (2010). Infrared spectroscopic study of lipid interaction in stratum corneum treated with transdermal absorption enhancers. Int J Pharm 389:18–23.
  • Patil UK, Saraogi R. (2014). Natural products as potential drug permeation enhancer in transdermal drug delivery system. Arch Dermatol Res 306:419–26.
  • Sarroukh R, Goormaghtigh E, Ruysschaert JM, et al. (2013). ATR-FTIR: a "rejuvenated" tool to investigate amyloid proteins. Biochim Biophys Acta 1828:2328–38.
  • Shi J, Cong W, Wang Y, et al. (2013). Synergistic effect and mechanism of cineole and terpineol on in-vitro transdermal delivery of huperzine A from microemulsions . Iran J Pharm Res 12:271–80.
  • Song W, Quan P, Li S, et al. (2016). Probing the role of chemical enhancers in facilitating drug release from patches: mechanistic insights based on FT-IR spectroscopy, molecularmodeling and thermal analysis. J Control Release 227:13–22.
  • Takahashi K, Sakano H, Yoshida M, et al. (2001). Characterization of the influence of polyol fatty acid esters on the permeation of diclofenac through rat skin. J Control Release 73:351–8.
  • Tan HS, Pfister WR. (1999). Pressure-sensitive adhesives for transdermal drug delivery systems. Pharm Sci Technol Today 2:60–9.
  • Thakur RA, Wang Y, Michniak BB, (2006). Essential oils and terpenes. In: Smith EW, Maibach HI, eds. Percutaneous penetration enhancers. Boca Raton (FL): CRC Press,159–73.
  • Varman RM, Singh S. (2012). Investigation of effects of terpene skin penetration enhancers on stability and biological activity of lysozyme. AAPS PharmSciTech 13:1084–90.
  • Wang T, Wang C, Li Y, et al. (2018). Effect of chiral isopropyl O-acylmenthol derivatives on in vitro permeation of metoprolol. J Shenyang Pharm Univ 35:163–9.
  • Wenkers BP, Lippold BC. (1999). Skin penetration of nonsteroidal antiinflammatory drugs out of a lipophilic vehicle: influence of the viable epidermis. J Pharm Sci 88:1326–31.
  • Williams AC, Barry BW. (2004). Penetration enhancers. Adv Drug Deliv Rev 56:603–18.
  • Kadhum WR, Sekiguchi S, Hijikuro I, et al. (2017). Esters of 6-aminohexanoic acid as skin permeation enhancers: transdermal delivery of atorvastatin calcium from novel nanovesicular systems using polyethylene glycol fatty acid esters: ameliorated effect without liver toxicity in poloxamer 407-induced hyperlipidemic rats. J Control Release 254:10–22.
  • Xie F, Chai JK, Hu Q, et al. (2016). Transdermal permeation of drugs with differing lipophilicity: effect of penetration enhancer camphor. Int J Pharm 507:90–101.
  • Zhao H, Liu C, Quan P, et al. (2017). Mechanism study on ion-pair complexes controlling skin permeability: effect of ion-pair dissociation in the viable epidermis on transdermal permeation of bisoprolol. Int J Pharm 532:29–36.
  • Zhao K, Singh J. (1998). Mechanisms of percutaneous absorption of tamoxifen by terpenes: eugenol, d-limonene and menthone. J Control Release 55:253–60.
  • Zhao L, Fang L, Xu Y, et al. (2008a). Transdermal delivery of penetrants with differing lipophilicities using O-acylmenthol derivatives as penetration enhancers. Eur J Pharm Biopharm 69:199–213.
  • Zhao L, Fang L, Xu Y, et al. (2008b). Effect of O-acylmenthol on transdermal delivery of drugs with different lipophilicity. Int J Pharm 352:92–103.
  • Zhao L, Li Y, Fang L, et al. (2009). Transdermal delivery of tolterodine by O-acylmenthol: in vitro/in vivo correlation. Int J Pharm 374:73–81.